Project description:Transciption start site expression was studied after knockdown of NIPBL cancer cell lines (A549, H358, H2228, 22RV1, VCAP, C106, SW620, HCT116, CAMA-1)
Project description:Gene expression was studied in melanoma cell lines with (SKMEL-23 and SKMEL-1128) or without (A375 and CLOL800) ALKATI expression. Effects on gene expression was also analyzed after knockdown of NIPBL in melanoma cell lines 501mel, COLO800 and A375